IP Library Granted Patent US 10,206,771
Granted Patent B2
US 10,206,771 · App. 14/257,475 · Granted Feb 19, 2019

Pelvic health implants and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,206,771
App. No.
14/257,475
Granted
Feb 19, 2019
Kind
B2
Abstract

Surgical articles, implants and components suitable for female pelvic health procedures are described.

Claims (27)

1. A surgical implant for treating a pelvic health disorder, comprising:

an implant material including a support portion, the support portion having a longitudinal axis and first and second longitudinal sides;

a first extension portion extending transverse to the longitudinal axis from the first longitudinal side;

a second extension portion extending transverse to the longitudinal axis from the second longitudinal side, such that the first and second extension portions are capable of extending to pelvic tissue of a patient while the support portion is positioned to support tissue of a vagina, a urethra, or a bladder neck;

a third extension portion extending in the direction of the longitudinal axis, transverse to the first and second extension portions;

a fourth extension portion extending in the direction of the longitudinal axis, transverse to the first and second extension portions; and

wherein at least one of the extension portions is provided with a connector to selectively engage a surgical needle device, the connector includes a length between a proximal end and a distal end, a sidewall extending along the length, and one or more apertures passing through the sidewall.

2. The implant of claim 1 , wherein each of the extension portions is provided with a connector adapted to selectively engage with a surgical needle device.

3. The implant of claim 1 , wherein the implant material is constructed at least in part of a mesh material.

4. The implant of claim 1 , wherein the implant material is constructed at least in part of a synthetic mesh material.

5. The implant of claim 1 , wherein the implant material is constructed at least in part of a bioabsorbable material.

6. The implant of claim 1 , wherein at least one of the extension portions includes an insertion sheath.

7. The implant of claim 1 , wherein each of the extension portions includes an insertion sheath.

8. A surgical implant system for treating a pelvic health disorder, comprising:

an implant including a support portion, the support portion having first and second longitudinal sides;

a first extension portion extending transverse to and out from the first longitudinal side;

a second extension portion extending transverse to and out from second longitudinal side;

a third extension portion extending in the direction of the first longitudinal side, transverse to the first extension portion;

a fourth extension portion extending in the direction of the second longitudinal side, transverse to the second extension portion, the third and fourth extension portions being capable of extending to a portion of pelvic tissue while the support portion is positioned to support tissue of a vagina, a urethra, or a bladder neck; and

wherein at least one of the extension portions includes a connector capable of being connected to a distal end of a surgical needle, the connector includes a length between a proximal end and a distal end, a sidewall extending along the length, and one or more holes passing through the sidewall.

9. The system of claim 8 , wherein the implant is constructed at least in part of a mesh material.

10. The system of claim 8 , wherein the implant is constructed at least in part of a bioabsorbable material.

11. The system of claim 8 , wherein at least one of the extension portions includes an insertion sheath.

12. The system of claim 8 , wherein the surgical needle includes a curved needle portion.

13. The system of claim 8 , wherein the connector includes a lumen.

14. The system of claim 8 , wherein the first and second extension portions are capable of extending to a portion of an obturator foramen.

15. The system of claim 8 , wherein the third and fourth extension portions are capable of extending to a portion of a sacrospinous ligament.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
RELEASE OF SECURITY INTEREST Recorded Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR PHARMACEUTICAL COMPANIES, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067239/0491 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Sep 17, 2021
From: ASTORA WOMEN'S HEALTH LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS INC.; PAR PHARMACEUTICAL, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 057538/0978 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2019
From: GOCHE, JOSEPH PETER, MR
To: LAWRENCE, RICK EUGENE, MR
Reel/Frame 049231/0012 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2018
From: ASTORA WOMEN'S HEALTH, LLC
To: STASKIN, DAVID, MD, DR
Reel/Frame 045605/0796 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA NAME PREVIOUSLY RECORDED AT REEL: 037300 FRAME: 0728. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Apr 21, 2017
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 042308/0630 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037551/0626 →
CHANGE OF NAME Recorded Jan 18, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037551/0749 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0728 →